Post Exercise Fatigue in Professional Athletes. Other fatigue
Conditions
Interventions
Intervention 1: First Intervention group: Received Analectra supplement manufactured by Salamat Parmon Amin Company (containing 200 mg magnesium oxide, 95 mg potassium chloride, 70 mg bromelain 2500GD
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Fill Written informed consent Ability to perform study exercise programs Age 18 to 35 years Having an exercise program for at least 4 days a week Have at least one year of football experience
Exclusion criteria
Exclusion criteria: Sensitivity to supplement components Taking anticoagulant and antiplatelet medications Any acute or chronic physical conditions that limit the implementation of the study's exercise program Having cardiovascular diseases Having kidney disease Having neurological diseases Having muscle diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delayed onset muscle soreness. Timepoint: Daily during each study period, 20 minute before each training session. Method of measurement: A numerical scale from 1 (no pain) to 10 (the most pain possible) in the form of a numerical rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of perceived exertion. Timepoint: Daily in each study period 20 minutes after the end of each exercise. Method of measurement: Visual Analogue Scale.;Adverse Effects. Timepoint: At the End of Each Study Period. Method of measurement: Reporting any Side Effects by Athletes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Rezazadeh
Iran University of Medical Sciences
Outcome results
None listed